No Massive FDA/NIH 'Cures' Overhaul At Senate
This article was originally published in Scrip
Executive Summary
Rather than releasing a massive draft piece of legislation aimed at overhauling the US biomedical enterprise, like the House Energy and Commerce Committee did a year ago – proposing big changes to the FDA and the National Institutes of Health (NIH) – the Senate Health, Education, Labor and Pensions (HELP) Committee has settled on taking a "step-by-step" approach.